The European Union may pay more than $10 billion to Pfizer and other companies to buy coronavirus vaccines.
Russian satellite news agency on November 20th, Reuters quoted anonymous representatives of the European Union participating in the talks as saying that the EU may pay more than $10 billion to obtain hundreds of millions of doses of Pfizer/BioNTech and CureVac’s coronavirus vaccine.
According to the above-mentioned representative, the EU agreed to pay 15.50 euros (over 18 US dollars) per dose of Pfizer/BioNTech vaccine. This means that the total price of 200 million doses of vaccine will be 3.1 billion euros (nearly $3.7 billion). At the same time, if another 100 million doses of vaccine will be purchased within the framework of the agreement, the price may rise to 4.56 billion euros.
According to Reuters, information on vaccine prices confirms that the EU pays less for each dose of vaccine than in the United States. The deal includes insurance for EU countries if they forward the vaccine to the United States, according to an anonymous source.
In addition, considering the preferential treatment of the first batch of 225 million doses of vaccines, the EU agreed to pay 10 euros (nearly 12 US dollars) for each dose of CureVac vaccine. The company previously priced it at 12 euros. According to the official, the company promised to start supplying vaccines at the end of March.
Previously, it was reported that the European Commission signed another contract with the European company CureVac to buy a vaccine on November 7. Under the contract, the EU will be able to obtain up to 405 million doses of the company’s vaccine.
The EU will pay €4.05 million ($4.8 billion) for 405 million doses of vaccines if the price of each dose is maintained at €10, according to Reuters